Manufacturing

Jeong Jin-hyeok is a lead specialist in drug product at Samsung Biologics.

Articles

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

Preparing for a New Wave of mRNA Technologies

Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling. 

Scaling Manufacturing Processes Using  Single-Use Technologies

Thermo Fisher Scientific’s new facility in Hangzhou, China, is designed to boost biologics and sterile development and manufacturing capabilities in the Asia-Pacific region.

Thermo Fisher Expands Biologics and Steriles Manufacturing Capabilities in China

Greg Swan is business development manager for Cell & Gene Therapy at Avantor.

Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.

Addressing Developmental Challenges of Gene Therapy Viral Vectors

Brian Mullan is the chief technical officer of Yposkesi, an SK Pharmteco company.

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

Choosing the Right CDMO for CGT Programs 

WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.

WuXi STA Opens a New Large-Scale Continuous Manufacturing Plant

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Demand spurs innovations in syringes and syringe fill/finish operations. 

Prefilled Syringes Show Strong Growth

MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.

MilliporeSigma to Supply Lotte Biologics with Biologics Manufacturing Capabilities in US

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.

Manufacturing, Biologic Drugs